Literature DB >> 6160439

Diagnostic ultrasound: early detection of fetal neural tube defects.

H P Robinson, V D Hood, A H Adam, A A Gibson, M A Ferguson-Smith.   

Abstract

In a series of 366 patients identified as at risk for a fetal neural tube defect (NTD) before the 24th week of pregnancy, 64 had an abnormal fetus. The abnormalities included anencephaly (39), open spinal defect (17), closed spinal defect (2), encephalocele (1), and a miscellany of other abnormalities (5). An ultrasound examinaton prior to diagnostic anmiocentesis positively identified all anencephalic fetuses, the fetus with the encephalocele, and 15 of the 19 fetuses with spina bifida. The spinal defects in 3 of the remaining 4 fetuses were demonstrated at a second examination. Since both amniotic fluid alpha-fetoprotein (AFP) assays and ultrasound examination have been shown to give false results in the diagnosis of NTDs, the importance of using 2 independent diagnostic techniques is stressed. In patients with elevated levels of maternal serum AFP, a careful ultrasound examination, in addition to identifying the majority of cases associated with an abnormal fetus, provided a good explanation for the elevation in over half of the remainder. In this series more than half the patients (40/69) who underwent amniocentesis because of raised maternal serum AFP levels were shown to have an abnormal fetus.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6160439

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.

Authors:  W Fuhrmann; H K Weitzel
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

2.  Diagnosis of brain neuropathology in utero.

Authors:  D H Pretorius; P D Russ; C M Rumack; M L Manco-Johnson
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

3.  Can we afford screening for neural tube defects? The South Wales experience.

Authors:  B M Hibbard; C J Roberts; G H Elder; K T Evans; K M Laurence
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.